Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Eur Heart J ; 31(12): 1449-56, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20231153

RESUMEN

AIMS: To determine the incidence and factors associated with heart rupture (HR) in acute coronary syndrome (ACS) patients. METHODS AND RESULTS: Among 60 198 patients, 273 (0.45%) had HR (free wall rupture, n = 118; ventricular septal rupture, n = 155). Incidence was 0.9% for ST-segment elevation myocardial infarction (STEMI), 0.17% for non-STEMI, and 0.25% for unstable angina. Hospital mortality was 58 vs. 4.5% in patients without HR (P < 0.001). The incidence was lower in STEMI patients with primary percutaneous coronary intervention (PCI) than in those without (0.7 vs. 1.1%; P = 0.01), but primary PCI was not independently related to HR in adjusted analysis (P = 0.20). Independent variables associated with HR included: ST-segment elevation (STE)/left bundle branch block; ST-segment deviation; female sex; previous stroke; positive initial cardiac biomarkers; older age; higher heart rate; systolic blood pressure/30 mmHg decrease. Conversely, previous MI and the use of low-molecular-weight heparin and beta-blockers during first 24 h were identified as protective factors for HR. CONCLUSION: The incidence of HR is low in patients with ACS, although its incidence is probably underestimated. Heart rupture occurs more frequently in ACS with STE and is associated with high hospital mortality. A number of variables are independently related to HR.


Asunto(s)
Síndrome Coronario Agudo/complicaciones , Angina Inestable/complicaciones , Rotura Cardíaca/etiología , Infarto del Miocardio/complicaciones , Síndrome Coronario Agudo/mortalidad , Síndrome Coronario Agudo/terapia , Antagonistas Adrenérgicos beta/uso terapéutico , Adulto , Anciano , Angina Inestable/mortalidad , Angina Inestable/terapia , Anticoagulantes/uso terapéutico , Estudios de Cohortes , Femenino , Fibrinolíticos/uso terapéutico , Rotura Cardíaca/mortalidad , Rotura Cardíaca/terapia , Rotura Cardíaca Posinfarto/etiología , Rotura Cardíaca Posinfarto/mortalidad , Rotura Cardíaca Posinfarto/terapia , Heparina de Bajo-Peso-Molecular/uso terapéutico , Mortalidad Hospitalaria , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Infarto del Miocardio/mortalidad , Infarto del Miocardio/terapia , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA